Valuation: Zai Lab Limited

Market Cap 269.78Cr 2.12TCr 240.91Cr 222.55Cr 201.68Cr 377.32Cr 26TCr 383.57Cr 2.68TCr 1.06TCr 13TCr 1.01TCr 990.91Cr 42TCr P/E 2026 *
-10.9x
P/E 2027 * -10.9x
Enterprise Value 224.01Cr 1.76TCr 200.04Cr 184.8Cr 167.47Cr 313.31Cr 21TCr 318.5Cr 2.22TCr 880.43Cr 11TCr 840.69Cr 822.81Cr 35TCr EV / Sales 2026 *
5.13x
EV / Sales 2027 * 4.2x
Free-Float
94.05%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Zai Lab Limited

1 day-0.34%
1 week-4.41%
Current month-13.86%
1 month-11.01%
3 months+15.60%
6 months+0.97%
Current year+30.26%
1 week 16.71
Extreme 16.71
20.06
1 month 16.71
Extreme 16.71
21
Current year 12.31
Extreme 12.31
21.42
1 year 12.31
Extreme 12.31
21.42
3 years 10.56
Extreme 10.56
35.5
5 years 10.56
Extreme 10.56
83.3
10 years 10.56
Extreme 10.56
151.2
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-4.41% - - 269.78Cr
-2.54%+1.31%+54.27%+114.96% 1,13500Cr
-1.42%+3.23%+38.56%+74.44% 64TCr
+0.16%+0.08%+25.29%+95.23% 50TCr
-0.31%+3.09%+44.14%+64.80% 38TCr
-1.34%-0.47%+66.04%+41.00% 36TCr
-0.68%+2.65%+22.98%+50.39% 29TCr
-1.20%+3.04%+2.33%+22.86% 27TCr
-1.79%+1.57%+50.56%+59.08% 24TCr
-0.73%-0.10%+29.02%+99.67% 19TCr
Average -1.02%+2.17%+37.02%+69.16% 44.49TCr
Weighted average by Cap. -1.35%+2.66%+41.02%+79.75%

Financials

2026 *2027 *
Net sales 44Cr 342.29Cr 39Cr 36Cr 33Cr 61Cr 4.14TCr 62Cr 433.3Cr 171.55Cr 2.17TCr 163.8Cr 160.32Cr 6.84TCr 55Cr 432.99Cr 49Cr 46Cr 41Cr 77Cr 5.24TCr 79Cr 548.12Cr 217Cr 2.75TCr 207.21Cr 202.8Cr 8.66TCr
Net income -24Cr -188.73Cr -21Cr -20Cr -18Cr -34Cr -2.28TCr -34Cr -238.91Cr -95Cr -1.2TCr -90Cr -88Cr -3.77TCr -21Cr -165.53Cr -19Cr -17Cr -16Cr -30Cr -2TCr -30Cr -209.54Cr -83Cr -1.05TCr -79Cr -78Cr -3.31TCr
Net Debt -46Cr -358.9Cr -41Cr -38Cr -34Cr -64Cr -4.34TCr -65Cr -454.33Cr -179.87Cr -2.28TCr -171.75Cr -168.1Cr -7.18TCr -38Cr -298.65Cr -34Cr -31Cr -28Cr -53Cr -3.62TCr -54Cr -378.05Cr -149.67Cr -1.89TCr -142.92Cr -139.88Cr -5.97TCr
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
23/26/23 HK$17.78 -0.34% 66,42,800
22/26/22 HK$17.84 -9.81% 44,45,700
21/26/21 HK$19.78 +4.88% 26,91,100
20/26/20 HK$18.86 +1.40% 23,40,500
16/26/16 HK$18.60 +3.62% 43,64,600
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.03USD
Average target price
33.14USD
Spread / Average Target
+37.91%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Zai Lab Limited